Mupirocin Focus Pharmaceuticals Ltd (Mupirocin)

• Mupirocin is a topical antibacterial agent used to manage skin infections caused by susceptible bacteria.
• Impetigo: Reduces bacterial load and promotes healing of superficial skin lesions.
• Secondary bacterial skin infections: Controls infection in compromised skin areas.
• Folliculitis: Eliminates bacterial colonisation of hair follicles and alleviates inflammation.

• Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, preventing the incorporation of isoleucine into nascent proteins. This blockade halts bacterial protein synthesis, leading to bacteriostatic activity at low concentrations and bactericidal effects at higher concentrations against susceptible Gram‑positive organisms.

Mupirocin may cause local skin reactions when applied.

Common Side Effects

• Application site irritation: mild redness or discomfort.
• Itching: localized pruritus at the site of use.
• Burning sensation: transient warmth during application.
• Dry skin: mild desiccation around the treated area.
• Pain: brief tenderness at the application site.
• Rash: non‑specific erythematous eruption.

Serious or Rare Side Effects

• Allergic contact dermatitis: severe itching, swelling, and blistering.
• Hypersensitivity reaction: systemic urticaria or angioedema.
• Stevens‑Johnson syndrome: rare, severe mucocutaneous reaction.
• Neutropenia: very rare systemic absorption leading to low white‑blood‑cell count.
• Severe skin necrosis: extensive tissue damage at the application site.

• Before using mupirocin, consider the following safety measures.
• Pregnancy: Consult a healthcare professional; safety data are limited.
• Breastfeeding: Avoid application on nipples if the infant may ingest the product.
• Age: Use with caution in children under two months unless directed by a clinician.
• Allergy: Discontinue immediately if signs of hypersensitivity appear.
• Concurrent antibiotic therapy: Monitor for potential resistance development.
• Store at ambient temperature: Keep in the original container, protect from moisture and light.

Mupirocin may interact with other medications, primarily affecting topical efficacy.

Major Interactions (Avoid)

• Systemic antibiotics (e.g., clindamycin): may reduce the topical agent's effectiveness.
• Other topical antibacterial agents: concurrent use can increase risk of local irritation.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids: may enhance systemic absorption of mupirocin.
• Occlusive dressings: can increase drug concentration and irritation.
• Antifungal creams: may alter skin flora and affect treatment outcome.